US$51.5 million in disclosed equity awards accompany HP CEO appointment

Walmsley takes charge with a sizeable equity package

HP Inc. (NYSE:HPQ) has recruited former GSK chief executive Emma Walmsley to lead the technology company from January 4, 2027, pairing the appointment with a disclosed equity package worth US$30 million at grant date. The appointment gives HP an external chief executive with experience in global consumer and healthcare businesses, but the filing provides no new financial targets or operating guidance.

Walmsley’s arrangements include a US$1.45 million annual base salary, a target bonus equal to 200% of salary and fiscal 2027 annual equity awards valued at US$6.45 million in time-vesting restricted stock units and US$15.05 million in performance-adjusted restricted stock units. Adding the annual awards to the separate inducement package means the disclosed grant-date values total US$51.5 million before salary, bonus and other benefits, although part of that amount remains tied to vesting and performance conditions.

The package also includes a US$2.5 million sign-on bonus, repayable on a prorated basis if Walmsley voluntarily leaves or is dismissed for misconduct within her first year, along with relocation benefits of up to US$2.5 million. The performance conditions for the inducement PARSUs are still to be approved by HP’s board in January 2027.

Interim CEO Broussard moves to the chair

Bruce Broussard, who has served as interim CEO since February 2026, will step down from that role at the end of January 3 and become chair when Walmsley starts. Chip Bergh will remain on the board after handing over the chair, having held the position since 2017.

HP says the board unanimously selected Walmsley after a global search and highlighted her leadership of GSK from 2017 to 2025, including a strategic focus on specialty medicines and vaccines, a strengthened research pipeline and the separation of GSK’s consumer healthcare business. Walmsley also sits on Microsoft’s board, while her earlier career included 17 years at L’Oréal.

HP points to AI while leaving the strategy unquantified

The company’s announcement frames the succession around artificial intelligence and the “future of work”, with Walmsley saying HP will seek new sources of growth from the AI era. Those statements set a strategic direction rather than a measurable forecast: the filing contains no revenue, margin, investment or product targets for the incoming CEO to deliver.

HP has amended its bylaws to increase the authorised board from 12 to 13 seats, allowing Walmsley to join the board when she becomes CEO. The immediate investor test is therefore less about the mechanics of the appointment than what Walmsley says after taking office, and whether the promised AI-led growth agenda can be translated into financial priorities without diluting the company’s existing execution focus.